BioSpace News Archive

Business

Mednow Achieves Record Q4 2022 Financial Results with +11% Q/Q Revenue Growth and 5,700% Y/Y Revenue Growth

Q4/22 revenue increased over 11% quarter-over-quarter, and more than 5,700% year-over-year.

November 29, 2022
·
14 min read
IIF: Digital Investor Conference on the 7th of December - The International Investment Forum (IIF)

The International Investment Forum (IIF) will take place on the 7th of December 2022, starting at 10:00 am (CET) | 04. 00 am (ET) until 07:30 pm (CET) | 01:30 pm (ET) .

November 29, 2022
·
1 min read
Policy

Investors who lost Money with shares of Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) should contact the Shareholders Foundation in connection with the Lawsuit against Ampio Pharmaceuticals, Inc.

The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Ampio Pharmaceuticals, Inc. (NYSE American: AMPE).

November 29, 2022
·
1 min read
Epigenetic Aging Explored At Largest Advanced Medical Education Event Of 2022

Industry experts in anti-aging and functional medicine will be meeting in Las Vegas this December, along with thousands of attendees from across the globe for Longevity Fest: the 30th Annual World Congress hosted by the Academy of Anti-Aging Medicine (A4M) on December 9th - 11th.

November 29, 2022
·
2 min read
Genetown

Conformis Announces First Procedure Performed Using New Actera™ Hip System

Conformis, Inc. today announced that the first procedure with the company’s new Actera™ Hip System has been performed.

November 29, 2022
·
5 min read
Business

Context Therapeutics® Nominates CTIM-76 Bispecific Antibody Candidate to Develop Treatment for Claudin 6-Positive Solid Tumors

Context Therapeutics Inc. today announced the selection of CTIM-76, a T cell-engaging bispecific antibody, as its lead clinical development candidate to target Claudin 6 (CLDN6) positive cancers, resulting from its research collaboration and licensing agreement with Integral Molecular.

November 29, 2022
·
5 min read
Drug Development

POINT Biopharma Releases New Preclinical Data Supporting the Combination of 177Lu-PNT6555 with Immunotherapy

POINT Biopharma Global Inc. today released new preclinical data from the Company’s pan-cancer fibroblast activation protein-α (FAP-α) targeted program, PNT2004.

November 29, 2022
·
6 min read
Business

KemPharm Announces Appointment of Christopher Posner as New Independent Director

KemPharm, Inc. today announced the appointment of Christopher Posner to serve on the Company’s Board of Directors.

November 29, 2022
·
6 min read
Business

Tomas J. Philipson, Former Acting Chairman of the White House Council of Economic Advisers, Joins GATC Health’s Advisory Board

GATC Health today announced that Tomas J. Philipson has joined its Medical Advisory Board.

November 29, 2022
·
4 min read
Genetown

Stoke Therapeutics to Present Data from the Company’s Dravet Syndrome Program at the American Epilepsy Society 2022 Annual Meeting

Seven abstracts related to the Company’s work in Dravet syndrome will be presented, including data from a combined interim analysis of the Phase 1/2a MONARCH and ADMIRAL studies of STK-001.

November 29, 2022
·
11 min read